Clinical Lipidology and Metabolic Disorders
Published by Taylor & Francis
eISSN : 2641-5321
Abbreviation : Clin. Lipidol. Metab. Disord.
Aims & Scope
Cessation.
The field of lipidology is developing rapidly.
Clinical Lipidology will help update those involved in all aspects of this field.
Because this is an Open Access journal, the information will be freely available to all.
Clinical Lipidology will consider original papers, reviews, commentaries, editorials, case reports and correspondence relating to the following areas: • Related cardiovascular diseases and atherosclerosis • Treatment of lipid-related disorders (including prevention) • Side effects of lipid-lowering medication and adherence to treatment • Cost-effectiveness • Obesity and the metabolic syndrome • Dietary measures (including nutraceuticals) • Summaries of newly approved therapeutic agents • Comments on recent clinical trials relevant to the field of lipidology • Diagnostic and clinical criteria • Research in emerging areas in the field of lipidology • Commentaries on guidelines, trials and other publications • Genetics • Epidemiology • Experimental models of dyslipidaemia • Case reports • Laboratory investigations and new biomarkers related to lipids
View Aims & ScopeAbstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.